GEN Exclusives

More »

GEN News Highlights

More »
Apr 24, 2013

Novartis Cuts 300 Jobs, Names New CFO

  • Reporting its first-quarter financial results this week, Novartis announced a restructuring of its Lincoln, Nebraska manufacturing plant affecting 300 positions—40% of the total workforce at that site. The pharma giant also named Harry Kirsch its new CFO.

    Novartis plans to reduce staff at the Nebraska plant in phases during the next two years, in order to shift its focus on two product forms, the company said. “This will enable the site to focus on operational excellence, with minimal product complexity,” according to a Novartis statement.

    Kirsch, who was previously CFO Pharmaceuticals, has been promoted to Group CFO, the company said. He replaces Jon Symonds, who is being made advisor to the CEO through the end of the year.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?